| Year |
Citation |
Score |
| 2023 |
Gonczi L, Lakatos L, Golovics PA, Angyal D, Balogh F, Ilias A, Pandur T, David G, Erdelyi Z, Szita I, Lakatos PL. Burden of perianal disease in Crohn's disease: Accelerating medical therapy and high rates of perianal surgery over the last four decades - Results from a population-based study over four decades. Alimentary Pharmacology & Therapeutics. PMID 38115207 DOI: 10.1111/apt.17836 |
0.319 |
|
| 2023 |
Wetwittayakhlang P, Verdon C, Starr M, Hahn GD, Golovics PA, Bessissow T, Afif W, Wild G, Bitton A, Lakatos PL. Mucosal Healing and Clinical Efficacy of Adalimumab in Small Intestinal Crohn's Disease (SIMCHA Study): Final Results From a Prospective, Open-Label, Single-Arm Study. The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology. PMID 37162506 DOI: 10.5152/tjg.2023.22527 |
0.315 |
|
| 2023 |
Wetwittayakhlang P, Gonczi L, Golovics PA, Kurti Z, Pandur T, David G, Erdelyi Z, Szita I, Lakatos L, Lakatos PL. Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977-2020. Journal of Clinical Medicine. 12. PMID 37109362 DOI: 10.3390/jcm12083026 |
0.312 |
|
| 2022 |
Kurti Z, Gonczi L, Lakatos L, Golovics P, Pandur T, David G, Erdelyi Z, Szita I, Lakatos PL. Epidemiology, treatment strategy, natural disease course and surgical outcomes of patients with ulcerative colitis in Western Hungary - a population-based study between 2007 and 2018, data from the Veszprem County cohort. Journal of Crohn's & Colitis. PMID 36125105 DOI: 10.1093/ecco-jcc/jjac142 |
0.337 |
|
| 2022 |
Gonczi L, Lakatos L, Kurti Z, Golovics P, Pandur T, David G, Erdelyi Z, Szita I, Lakatos PL. Incidence, prevalence, disease course and treatment strategy of Crohn's disease patients from the Veszprem cohort, Western Hungary - a population-based inception cohort study between 2007 and 2018. Journal of Crohn's & Colitis. PMID 36087109 DOI: 10.1093/ecco-jcc/jjac132 |
0.354 |
|
| 2022 |
Hahn GD, Golovics PA, Wetwittayakhlang P, Al Khoury A, Bessissow T, Lakatos PL. Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing? Biomedicines. 10. PMID 35453498 DOI: 10.3390/biomedicines10040749 |
0.308 |
|
| 2022 |
Guillo L, Abreu M, Panaccione R, Sandborn WJ, Azevedo VF, Gensler L, Moghaddam B, Ahuja V, Ali SA, Allez M, Ananthakrishnan AN, Bhattacharya A, Dubinsky M, Griffiths A, Hart A, ... ... Lakatos PL, et al. Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. The Lancet. Gastroenterology & Hepatology. PMID 35051383 DOI: 10.1016/S2468-1253(21)00297-1 |
0.311 |
|
| 2021 |
Wetwittayakhlang P, Albader F, Golovics PA, Hahn GD, Bessissow T, Bitton A, Afif W, Wild G, Lakatos PL. Clinical Outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease. Canadian Journal of Gastroenterology & Hepatology. 2021: 7591141. PMID 34858891 DOI: 10.1155/2021/7591141 |
0.331 |
|
| 2021 |
Al Khoury A, Balram B, Bessissow T, Afif W, Gonczi L, Abreu M, Lakatos PL. Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review. Digestive Diseases and Sciences. PMID 34021425 DOI: 10.1007/s10620-021-07025-y |
0.33 |
|
| 2021 |
Zhao M, Gönczi L, Lakatos PL, Burisch J. The burden of inflammatory bowel disease in Europe in 2020. Journal of Crohn's & Colitis. PMID 33582812 DOI: 10.1093/ecco-jcc/jjab029 |
0.347 |
|
| 2020 |
Al Khoury A, Singh K, Kurti Z, Gonczi L, Golovics P, Kohen R, Afif W, Wild G, Bitton A, Bessissow T, Lakatos PL. The Burden of Anemia Remains Significant over Time in Patients with Inflammatory Bowel Diseases at a Tertiary Referral Center. Journal of Gastrointestinal and Liver Diseases : Jgld. 29: 555-559. PMID 33331351 DOI: 10.15403/jgld-2705 |
0.328 |
|
| 2020 |
Burisch J, Bergemalm D, Halfvarson J, Domislovic V, Krznaric Z, Goldis A, Dahlerup JF, Oksanen P, Collin P, de Castro L, Hernandez V, Turcan S, Belousova E, D'Incà R, Sartini A, ... ... Lakatos PL, et al. The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study. United European Gastroenterology Journal. 2050640620945949. PMID 32715989 DOI: 10.1177/2050640620945949 |
0.325 |
|
| 2020 |
Verdon C, Reinglas J, Coulombe J, Gonczi L, Bessissow T, Afif W, Vutcovici M, Wild G, Seidman EG, Bitton A, Brassard P, Lakatos PL. No Change in Surgical and Hospitalization Trends Despite Higher Exposure to Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease in the Québec Provincial Database From 1996 to 2015. Inflammatory Bowel Diseases. PMID 32676662 DOI: 10.1093/ibd/izaa166 |
0.336 |
|
| 2020 |
Balram B, Lubov J, Theoret Y, Afif W, Bitton A, Wild G, Lakatos PL, Bessissow T. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy. Digestive Diseases and Sciences. PMID 32591969 DOI: 10.1007/s10620-020-06427-8 |
0.322 |
|
| 2020 |
Alrajhi S, Germain P, Martel M, Lakatos P, Bessissow T, Al-Taweel T, Afif W. Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease. Intestinal Research. PMID 32182640 DOI: 10.5217/Ir.2019.00116 |
0.357 |
|
| 2020 |
Nene S, Gonczi L, Kurti Z, Morin I, Chavez K, Verdon C, Reinglas J, Kohen R, Bessissow T, Afif W, Wild G, Seidman E, Bitton A, Lakatos PL. Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes. World Journal of Gastroenterology. 26: 759-769. PMID 32116423 DOI: 10.3748/Wjg.V26.I7.759 |
0.318 |
|
| 2019 |
Hirten RP, Lakatos PL, Halfvarson J, Colombel JF. A Users Guide to De-escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 31887444 DOI: 10.1016/j.cgh.2019.12.019 |
0.351 |
|
| 2019 |
Gonczi L, Lakatos PL. Can We Say No to the 'Nocebo Effect' in Inflammatory Bowel Diseases? Journal of Crohn's & Colitis. PMID 31329840 DOI: 10.1093/ecco-jcc/jjz098 |
0.312 |
|
| 2019 |
Loo SY, Vutcovici M, Bitton A, Lakatos PL, Azoulay L, Suissa S, Brassard P. Risk of malignant cancers in inflammatory bowel disease. Journal of Crohn's & Colitis. PMID 30874294 DOI: 10.1093/ecco-jcc/jjz058 |
0.322 |
|
| 2019 |
Heron, Bessissow T, Bitton A, Lakatos P, Seidman E, Jain A, Battat R, Germain P, Lemieux C, Afif W. P533 Ustekinumab therapeutic drug monitoring in Crohn’s disease patients with loss of response Journal of Crohns & Colitis. 13. DOI: 10.1093/Ecco-Jcc/Jjy222.657 |
0.34 |
|
| 2019 |
Gonczi L, Ilias A, Szanto K, Kurti Z, Golovics PA, Farkas K, Schafer E, Szepes Z, Szalay B, Vincze A, Szamosi T, Molnar T, Lakatos P. P409 Non-medical reverse switch between the originator infliximab and its biosimilar in patients with inflammatory bowel disease: clinical outcomes and therapeutic drug monitoring Journal of Crohns & Colitis. 13. DOI: 10.1093/Ecco-Jcc/Jjy222.533 |
0.369 |
|
| 2019 |
Verdon C, Kopylov U, Chao CY, Restellini-Kherad S, Girardin M, Afif W, Lakatos P, Bessissow T, Bitton A, Seidman E. P177 Small intestinal mucosal healing assessed by video capsule endoscopy in Crohn’s disease patient treated with adalimumab: The SIMCHA study—interim results Journal of Crohns & Colitis. 13. DOI: 10.1093/Ecco-Jcc/Jjy222.301 |
0.384 |
|
| 2019 |
Verdon C, Reinglas J, Coulombe J, Gonczi L, Bessissow T, Afif W, Vutcovici M, Wild G, Seidman E, Bitton A, Brassard P, Lakatos P. DOP75 Surgery and hospitalisations rates in inflammatory bowel disease patients in the Québec provincial database from 199–6 to 2015 Journal of Crohn's and Colitis. 13: S075-S076. DOI: 10.1093/Ecco-Jcc/Jjy222.109 |
0.398 |
|
| 2018 |
Burisch J, Chetcuti Zammit S, Ellul P, Turcan S, Duricova D, Bortlik M, Winther Andersen K, Andersen V, Kaimakliotis IP, Fumery M, Gower-Rousseau C, Girardin G, Valpiani D, Goldis A, Brinar M, ... ... Lakatos PL, et al. Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort - an Epi-IBD study. Journal of Gastroenterology and Hepatology. PMID 30562421 DOI: 10.1111/jgh.14563 |
0.396 |
|
| 2018 |
Côté-Daigneault J, Bessissow T, Nicolae MV, Nie R, Bitton A, Lakatos PL, Brassard P. Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study. Inflammatory Bowel Diseases. PMID 30295818 DOI: 10.1093/ibd/izy311 |
0.346 |
|
| 2018 |
Burisch J, Katsanos KH, Christodoulou DK, Barros L, Magro F, Pedersen N, Kjeldsen J, Vegh Z, Lakatos PL, Eriksson C, Halfvarson J, Fumery M, Gower-Rousseau C, Brinar M, Cukovic-Cavka S, et al. Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort-An Epi-IBD Study. Journal of Crohn's & Colitis. PMID 30289522 DOI: 10.1093/ecco-jcc/jjy154 |
0.337 |
|
| 2018 |
Balram B, Battat R, Al-Khoury A, D'Aoust J, Afif W, Bitton A, Lakatos PL, Bessissow T. Risk factors associated with Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis. Journal of Crohn's & Colitis. PMID 30247650 DOI: 10.1093/ecco-jcc/jjy143 |
0.315 |
|
| 2018 |
Saroli Palumbo C, Restellini S, Chao CY, Aruljothy A, Lemieux C, Wild G, Afif W, Lakatos PL, Bitton A, Cocciolillo S, Ghali P, Bessissow T, Sebastiani G. Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography. Inflammatory Bowel Diseases. PMID 29889226 DOI: 10.1093/ibd/izy200 |
0.305 |
|
| 2018 |
Kurti Z, Ilias A, Gonczi L, Vegh Z, Fadgyas-Freyler P, Korponay G, Golovics PA, Lovasz BD, Lakatos PL. Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database. Bmc Gastroenterology. 18: 23. PMID 29378524 DOI: 10.1186/s12876-018-0746-6 |
0.344 |
|
| 2018 |
Burisch J, Kiudelis G, Kupcinskas L, Kievit HAL, Andersen KW, Andersen V, Salupere R, Pedersen N, Kjeldsen J, D'Incà R, Valpiani D, Schwartz D, Odes S, Olsen J, Nielsen KR, ... ... Lakatos PL, et al. Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study. Gut. PMID 29363534 DOI: 10.1136/gutjnl-2017-315568 |
0.374 |
|
| 2018 |
Heron V, Restellini S, Bessissow T, Lemieux C, Lakatos P, Wild G, Seidman E, Bitton A, Afif W. P438 Reinduction with ustekinumab in Crohn’s disease patients with a loss of response to treatment Journal of Crohns & Colitis. 12. DOI: 10.1093/Ecco-Jcc/Jjx180.565 |
0.366 |
|
| 2018 |
Reinglas J, Nene S, Gonczi L, Kurti Z, Restellini S, Kohen R, Afif W, Bessissow T, Wild G, Seidman E, Bitton A, Lakatos P. P411 Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease centre: Accessibility, resource utilisation and outcomes Journal of Crohns & Colitis. 12. DOI: 10.1093/Ecco-Jcc/Jjx180.538 |
0.355 |
|
| 2017 |
Burisch J, Vegh Z, Katsanos KH, Christodoulou DK, Lazar D, Goldis A, O'Morain C, Fernandez A, Pereira S, Myers S, Sebastian S, Pedersen N, Olsen J, Nielsen KR, Schwartz D, ... ... Lakatos PL, et al. Occurrence of anaemia in the first year of inflammatory bowel disease in a European population-based inception cohort - An ECCO-EpiCom study. Journal of Crohn's & Colitis. PMID 28575481 DOI: 10.1093/ecco-jcc/jjx077 |
0.317 |
|
| 2017 |
Vegh Z, Macsai E, Lakatos L, Lakatos PL. The incidence of glomerulonephritis in a population-based inception cohort of patients with inflammatory bowel disease. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 28462885 DOI: 10.1016/j.dld.2017.03.029 |
0.345 |
|
| 2017 |
Vegh Z, Kurti Z, Golovics PA, Lakatos PL. Can we predict disease course with clinical factors? Current Drug Targets. PMID 28378692 DOI: 10.2174/1389450118666170329095123 |
0.36 |
|
| 2016 |
Gönczi L, Kürti Z, Golovics P, Végh Z, Lovász B, Dorkó A, Seres A, Sümegi L, Menyhárt O, Kiss L, Papp J, Gecse K, Lakatos PL. [Indications, diagnoses and quality markers in upper and lower endoscopies in 2010 and 2011 at the 1st Department of Medicine, Semmelweis University, Budapest]. Orvosi Hetilap. 157: 2074-2081. PMID 28019112 DOI: 10.1556/650.2016.30602 |
0.557 |
|
| 2016 |
Siegel CA, Whitman CB, Spiegel BM, Feagan B, Sands B, Loftus EV, Panaccione R, D'Haens G, Bernstein CN, Gearry R, Ng SC, Mantzaris GJ, Sartor B, Silverberg MS, Riddell R, ... ... Lakatos PL, et al. Development of an index to define overall disease severity in IBD. Gut. PMID 27780886 DOI: 10.1136/Gutjnl-2016-312648 |
0.304 |
|
| 2016 |
Kurti Z, Vegh Z, Golovics PA, Fadgyas-Freyler P, Gecse KB, Gonczi L, Gimesi-Orszagh J, Lovasz BD, Lakatos PL. Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. PMID 27481587 DOI: 10.1016/j.dld.2016.07.012 |
0.339 |
|
| 2016 |
Vegh Z, Kurti Z, Gonczi L, Golovics PA, Lovasz BD, Szita I, Balogh M, Pandur T, Vavricka SR, Rogler G, Lakatos L, Lakatos PL. Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease. Scandinavian Journal of Gastroenterology. 51: 848-54. PMID 26880133 DOI: 10.3109/00365521.2016.1140807 |
0.356 |
|
| 2016 |
Lakatos P, Takács I, Marton I, Tóth E, Zoltan C, Lang Z, Psachoulia E, Intorcia M. A Retrospective Longitudinal Database Study of Persistence and Compliance with Treatment of Osteoporosis in Hungary. Calcified Tissue International. 98: 215-25. PMID 26686694 DOI: 10.1007/S00223-015-0082-6 |
0.31 |
|
| 2016 |
Gecse KB, Végh Z, Lakatos PL. Optimizing biological therapy in Crohn's disease. Expert Review of Gastroenterology & Hepatology. 10: 37-45. PMID 26471077 DOI: 10.1586/17474124.2016.1096198 |
0.311 |
|
| 2016 |
Fiorino G, Cortes P, Ellul P, Felice C, Karatzas P, Silva M, Lakatos P, Bossa F, Sebastian S, Ungar B, Furfaro F, Karmiris K, Katsanos K, Muscat M, Christodoulou D, et al. PTU-072 Discontinuation of Infliximab in Patients with Ulcerative Colitis is Associated with Increased Risk of Relapse: A Multinational Retrospective Cohort Study Gut. 65. DOI: 10.1136/Gutjnl-2016-312388.157 |
0.344 |
|
| 2015 |
Kurti Z, Lovasz BD, Gecse KB, Balint A, Farkas K, Morocza-Szabo A, Gyurcsanyi A, Kristof K, Vegh Z, Gonczi L, Kiss LS, Golovics PA, Lakatos L, Molnar T, Lakatos PL. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease. Journal of Gastrointestinal and Liver Diseases : Jgld. 24: 467-72. PMID 26697573 DOI: 10.15403/Jgld.2014.1121.244.Bcg |
0.612 |
|
| 2015 |
Golovics PA, Lakatos L, Mandel MD, Lovasz BD, Vegh Z, Kurti Z, Szita I, Kiss LS, Balogh M, Pandur T, Lakatos PL. Does Hospitalization Predict the Disease Course in Ulcerative Colitis? Prevalence and Predictors of Hospitalization and Re-Hospitalization in Ulcerative Colitis in a Population-based Inception Cohort (2000-2012). Journal of Gastrointestinal and Liver Diseases : Jgld. 24: 287-92. PMID 26405700 DOI: 10.15403/Jgld.2014.1121.243.Pag |
0.604 |
|
| 2015 |
Lakatos PL, Sipeki N, Kovacs G, Palyu E, Norman GL, Shums Z, Golovics PA, Lovasz BD, Antal-Szalmas P, Papp M. Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn's Disease. Journal of Crohn's & Colitis. 9: 891-8. PMID 26188353 DOI: 10.1093/ecco-jcc/jjv127 |
0.321 |
|
| 2015 |
Golovics PA, Lakatos L, Mandel MD, Lovasz BD, Vegh Z, Kurti Z, Szita I, Kiss LS, Pandur T, Lakatos PL. Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012. World Journal of Gastroenterology : Wjg. 21: 7272-80. PMID 26109815 DOI: 10.3748/Wjg.V21.I23.7272 |
0.613 |
|
| 2015 |
Sipeki N, Davida L, Palyu E, Altorjay I, Harsfalvi J, Antal Szalmas P, Szabo Z, Veres G, Shums Z, Norman GL, Lakatos PL, Papp M. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease. World Journal of Gastroenterology : Wjg. 21: 6952-64. PMID 26078573 DOI: 10.3748/wjg.v21.i22.6952 |
0.328 |
|
| 2015 |
Kurti Z, Lovasz BD, Mandel MD, Csima Z, Golovics PA, Csako BD, Mohas A, Gönczi L, Gecse KB, Kiss LS, Szathmari M, Lakatos PL. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. World Journal of Gastroenterology : Wjg. 21: 6728-35. PMID 26074711 DOI: 10.3748/Wjg.V21.I21.6728 |
0.567 |
|
| 2015 |
Donáth J, Speer G, Kósa JP, Árvai K, Balla B, Juhász P, Lakatos P, Poór G. Polymorphisms of CSF1 and TM7SF4 genes in a case of mild juvenile Paget's disease found using next-generation sequencing. Croatian Medical Journal. 56: 145-51. PMID 25891874 DOI: 10.3325/Cmj.2015.56.145 |
0.307 |
|
| 2015 |
Horváth VJ, Tabák GÁ, Szabó G, Putz Z, Koós CG, Lakatos P. [Cardiovascular side effects of non-steroidal anti-inflammatory drugs in the light of recent recommendations. Diclofenac is not more dangerous]. Orvosi Hetilap. 156: 516-20. PMID 25796279 DOI: 10.1556/Oh.2015.30120 |
0.306 |
|
| 2015 |
Vegh Z, Golovics PA, Lovasz BD, Kurti Z, Gecse KB, Szita I, Balogh M, Pandur T, Lakatos L, Lakatos PL. Low incidence of venous thromboembolism in inflammatory bowel diseases: prevalence and predictors from a population-based inception cohort. Scandinavian Journal of Gastroenterology. 50: 306-11. PMID 25471148 DOI: 10.3109/00365521.2014.985708 |
0.333 |
|
| 2015 |
Gecse K, Farkas K, Lovász B, Banai J, Bene L, Gasztonyi B, Golovics P, Kristóf T, Lakatos L, Miheller P, Nagy F, Palatka K, Papp M, Patai V, Salamon Á, ... ... Lakatos P, et al. Biosimilar Infliximab in inflammatory bowel diseases: First interim results from a prospective nationwide observational cohort Zeitschrift Fur Gastroenterologie. 53. DOI: 10.1055/S-0035-1551853 |
0.441 |
|
| 2014 |
Vaszilko M, Kovacs E, Restar L, Balla B, Cseplo K, Kosa J, Lakatos P. Potential significance of antiestrogen therapy in the development of bisphosphonate related osteonecrosis of the jaw. Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association For Cranio-Maxillo-Facial Surgery. 42: 1932-6. PMID 25316650 DOI: 10.1016/J.Jcms.2014.08.002 |
0.321 |
|
| 2014 |
Mandel MD, Balint A, Golovics PA, Vegh Z, Mohas A, Szilagyi B, Szabo A, Kurti Z, Kiss LS, Lovasz BD, Gecse KB, Farkas K, Molnar T, Lakatos PL. Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: Results from two referral centres. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 46: 985-90. PMID 25156871 DOI: 10.1016/J.Dld.2014.07.168 |
0.607 |
|
| 2014 |
Duricova D, Burisch J, Jess T, Gower-Rousseau C, Lakatos PL. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. Journal of Crohn's & Colitis. 8: 1351-61. PMID 24951261 DOI: 10.1016/j.crohns.2014.05.006 |
0.366 |
|
| 2014 |
Mandel MD, Michael MD, Bálint A, Lovász BD, Gulácsi L, Strbák B, Golovics PA, Farkas K, Kürti Z, Szilágyi BK, Mohás A, Molnár T, Lakatos PL. Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics. The European Journal of Health Economics : Hepac : Health Economics in Prevention and Care. 15: S121-8. PMID 24832845 DOI: 10.1007/S10198-014-0603-7 |
0.354 |
|
| 2014 |
Papp M, Lakatos PL. Serological studies in inflammatory bowel disease: how important are they? Current Opinion in Gastroenterology. 30: 359-64. PMID 24811052 DOI: 10.1097/MOG.0000000000000076 |
0.303 |
|
| 2014 |
Kovács M, Müller KE, Papp M, Lakatos PL, Csöndes M, Veres G. New serological markers in pediatric patients with inflammatory bowel disease. World Journal of Gastroenterology : Wjg. 20: 4873-82. PMID 24803798 DOI: 10.3748/wjg.v20.i17.4873 |
0.341 |
|
| 2014 |
Golovics PA, Mandel MD, Lovasz BD, Lakatos PL. Inflammatory bowel disease course in Crohn's disease: is the natural history changing? World Journal of Gastroenterology : Wjg. 20: 3198-207. PMID 24696605 DOI: 10.3748/wjg.v20.i12.3198 |
0.376 |
|
| 2014 |
Farkas K, Lakatos PL, Szűcs M, Pallagi-Kunstár É, Bálint A, Nagy F, Szepes Z, Vass N, Kiss LS, Wittmann T, Molnár T. Frequency and prognostic role of mucosal healing in patients with Crohn's disease and ulcerative colitis after one-year of biological therapy. World Journal of Gastroenterology : Wjg. 20: 2995-3001. PMID 24659890 DOI: 10.3748/wjg.v20.i11.2995 |
0.649 |
|
| 2014 |
Lovasz BD, Lakatos L, Horvath A, Pandur T, Erdelyi Z, Balogh M, Szipocs I, Vegh Z, Veres G, Müller KE, Golovics PA, Kiss LS, Mandel MD, Lakatos PL. Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 46: 405-11. PMID 24495511 DOI: 10.1016/J.Dld.2013.12.013 |
0.677 |
|
| 2014 |
Szabó D, Kökönyei G, Arató A, Dezsőfi A, Molnár K, Müller KE, Lakatos PL, Papp M, Lovász BD, Golovics PA, Cseh A, Veres G. Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease. Journal of Crohn's & Colitis. 8: 747-55. PMID 24434181 DOI: 10.1016/j.crohns.2013.12.020 |
0.335 |
|
| 2014 |
Burisch J, Pedersen N, Cukovic-Cavka S, Turk N, Kaimakliotis I, Duricova D, Shonová O, Vind I, Avnstrøm S, Thorsgaard N, Krabbe S, Andersen V, Dahlerup Jens F, Kjeldsen J, Salupere R, ... ... Lakatos PL, et al. Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort. Inflammatory Bowel Diseases. 20: 36-46. PMID 24252978 DOI: 10.1097/01.MIB.0000436277.13917.c4 |
0.36 |
|
| 2014 |
Veres G, Registry H, Koós K, Papp M, Lakatos P. P638 Characteristics of Gipsy pediatric patients with inflammatory bowel disease (IBD) based on the nationwide, prospective Hungarian pediatric IBD registry (HUPIR) Journal of Crohn's and Colitis. 8. DOI: 10.1016/S1873-9946(14)60758-3 |
0.45 |
|
| 2014 |
Golovics P, Balint A, Mandel M, Vegh Z, Mohas A, Szilagyi B, Szabo A, Kurti Z, Kiss L, Lovasz B, Farkas K, Molnar T, Lakatos P. P468 Hospitalization rate before and after anti-TNF therapy, results from two referral centers Journal of Crohn's and Colitis. 8: S261. DOI: 10.1016/S1873-9946(14)60588-2 |
0.611 |
|
| 2014 |
Golovics P, Szabo A, Mandel M, Gyurcsanyi A, Kristof K, Vegh Z, Mohas A, Szilagyi B, Kurti Z, Csako B, Kiss L, Lovasz B, Gecse K, Lakatos P. P197 Is the tuberculin skin test alone accurate in moderate-to-severe BCG vaccinated patients with inflammatory bowel disease to test for latent tuberculosis? Journal of Crohn's and Colitis. 8: S144. DOI: 10.1016/S1873-9946(14)60318-4 |
0.638 |
|
| 2014 |
Golovics P, Mandel M, Lovasz B, Vegh Z, Szita I, Kiss L, Balogh M, Mohas A, Szilagyi B, Pandur T, Lakatos L, Lakatos P. DOP048 Is hospitalization predicting the disease course in Crohn's disease? Prevalence and predictors of hospitalization and re-hospitalization in Crohn's disease in a population based inception cohort between 2000–2012 Journal of Crohn's and Colitis. 8: S37-S38. DOI: 10.1016/S1873-9946(14)60073-8 |
0.666 |
|
| 2014 |
Lovasz B, Mandel M, Golovics P, Szita I, Vegh Z, Kiss L, Horvath A, Pandur T, Balogh M, Mohas A, Szilagyi B, Lakatos L, Lakatos P. DOP047 Is hospitalization predicting the disease course in UC? Prevalence and predictors of hospitalization and re-hospitalization in ulcerative colitis in a population-based inception cohort between 2000–2012 Journal of Crohn's and Colitis. 8: S37. DOI: 10.1016/S1873-9946(14)60072-6 |
0.631 |
|
| 2014 |
Mandel M, Balint A, Lovasz B, Kiss L, Golovics P, Vegh Z, Farkas K, Molnar T, Mohas A, Szilagyi B, Lakatos P. DOP027 Work disability in patients with inflammatory bowel diseases. Final report from two referral centers Journal of Crohn's and Colitis. 8: S27. DOI: 10.1016/S1873-9946(14)60052-0 |
0.687 |
|
| 2013 |
Golovics PA, Lakatos L, Nagy A, Pandur T, Szita I, Balogh M, Molnar C, Komaromi E, Lovasz BD, Mandel M, Veres G, Kiss LS, Vegh Z, Lakatos PL. Is early limited surgery associated with a more benign disease course in Crohn's disease? World Journal of Gastroenterology : Wjg. 19: 7701-10. PMID 24282358 DOI: 10.3748/Wjg.V19.I43.7701 |
0.653 |
|
| 2013 |
Müller KE, Lakatos PL, Papp M, Veres G. [Frequency and characteristics of granulomas in 368 pediatric patients with Crohn's disease]. Orvosi Hetilap. 154: 1702-8. PMID 24140509 DOI: 10.1556/OH.2013.29725 |
0.345 |
|
| 2013 |
Lovasz BD, Lakatos L, Golovics PA, David G, Pandur T, Erdelyi Z, Balogh M, Szita I, Molnar C, Komaromi E, Vegh Z, Mandel MD, Kiss LS, Lakatos PL. Risk of colorectal cancer in Crohn's disease patients with colonic involvement and stenosing disease in a population-based cohort from Hungary. Journal of Gastrointestinal and Liver Diseases : Jgld. 22: 265-8. PMID 24078982 |
0.664 |
|
| 2013 |
Müller KE, Lakatos PL, Arató A, Kovács JB, Várkonyi Ã, Szűcs D, Szakos E, Sólyom E, Kovács M, Polgár M, Nemes É, Guthy I, Tokodi I, Tóth G, Horváth Ã, et al. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 57: 576-82. PMID 23820399 DOI: 10.1097/MPG.0b013e31829f7d8c |
0.366 |
|
| 2013 |
Kiss LS, Lovasz BD, Golovics PA, Vegh Z, Farkas K, Molnar T, Palatka K, Papp M, Mohas A, Szilagyi BK, Fekete SA, Mandel M, Lakatos PL. Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα. Journal of Gastrointestinal and Liver Diseases : Jgld. 22: 135-40. PMID 23799211 |
0.64 |
|
| 2013 |
Miheller P, Kiss LS, Mandel M, Lakatos PL. Methotrexate: should we start using it in clinical practice? Current Drug Targets. 14: 1480-9. PMID 23651163 DOI: 10.2174/13894501113149990604 |
0.666 |
|
| 2013 |
Lovasz BD, Lakatos L, Horvath A, Szita I, Pandur T, Mandel M, Vegh Z, Golovics PA, Mester G, Balogh M, Molnar C, Komaromi E, Kiss LS, Lakatos PL. Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort. World Journal of Gastroenterology : Wjg. 19: 2217-26. PMID 23599648 DOI: 10.3748/Wjg.V19.I14.2217 |
0.651 |
|
| 2013 |
Fehérvári M, Sarkadi H, Krepuska M, Sótonyi P, Acsády G, Entz L, Lakatos P, Szeberin Z. Bone mineral density is associated with site-specific atherosclerosis in patients with severe peripheral artery disease. Calcified Tissue International. 93: 55-61. PMID 23564349 DOI: 10.1007/S00223-013-9727-5 |
0.332 |
|
| 2013 |
Fehérvári M, Krepuska M, Csobay-Novák C, Lakatos P, Oláh Z, Acsády G, Szeberin Z. [Prevalence of osteoporosis in patients with severe peripheral artery disease]. Orvosi Hetilap. 154: 369-75. PMID 23461977 DOI: 10.1556/Oh.2013.29532 |
0.37 |
|
| 2013 |
Lakatos PL, Vegh Z, Lovasz BD, David G, Pandur T, Erdelyi Z, Szita I, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics PA, Mandel M, Horvath A, et al. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. Inflammatory Bowel Diseases. 19: 1010-7. PMID 23399739 DOI: 10.1097/Mib.0B013E3182802B3E |
0.648 |
|
| 2013 |
Burisch J, Jess T, Martinato M, Lakatos PL. The burden of inflammatory bowel disease in Europe. Journal of Crohn's & Colitis. 7: 322-37. PMID 23395397 DOI: 10.1016/j.crohns.2013.01.010 |
0.33 |
|
| 2013 |
Miheller P, Kiss LS, Juhasz M, Mandel M, Lakatos PL. Recommendations for identifying Crohn's disease patients with poor prognosis. Expert Review of Clinical Immunology. 9: 65-75; quiz 76. PMID 23256765 DOI: 10.1586/Eci.12.86 |
0.673 |
|
| 2013 |
Lakatos PL, Lovasz BD, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics PA, Vegh Z, Mandel M, Horvath A, Szathmari M, et al. The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe. Journal of Crohn's & Colitis. 7: 385-91. PMID 22766526 DOI: 10.1016/J.Crohns.2012.06.011 |
0.667 |
|
| 2013 |
Kovacs M, Papp M, Lakatos PL, Jacobsen S, Nemes E, Polgar M, Solyom E, Bodi P, Horvath A, Molnar K, Szabo D, Cseh A, Muller KE, Dezsofi A, Arato A, et al. Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease. Journal of Crohn's & Colitis. 7: 134-41. PMID 22504031 DOI: 10.1016/j.crohns.2012.03.008 |
0.333 |
|
| 2013 |
Donath J, Speer G, Kosa J, Lakatos P, Poor G. The possibility rule of new mutations in juvenile Paget's disease (A rare case of mild JPD) Bone Abstracts. DOI: 10.1530/Boneabs.1.Pp3 |
0.318 |
|
| 2013 |
Muller K, Papp M, Lakatos P, Veres G. P663 A nation-wide registry of paediatric inflammatory bowel disease: improvement of diagnostic workup and Paris Classification Journal of Crohn's and Colitis. 7. DOI: 10.1016/S1873-9946(13)60684-4 |
0.401 |
|
| 2013 |
Golovics P, Lakatos L, Lovasz B, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szita I, Molnar C, Komaromi E, Vegh Z, Mandel M, Kiss L, Lakatos P. P624 Risk of colorectal cancer in CD patients with colonic involvement and stenosing disease. Results from a population-based study Journal of Crohn's and Colitis. 7: S261. DOI: 10.1016/S1873-9946(13)60645-5 |
0.665 |
|
| 2013 |
Reinisch W, Chowers Y, Danese S, Dignass A, Gomollón F, Nielsen OH, Lakatos P, Lees C, Lindgren S, Lukas M, Mantzaris G, Michetti P, Moum B, Biroulet LP, Toruner M, et al. P435 Management of iron deficiency in inflammatory bowel disease: results from a RAND/UCLA appropriateness study Journal of Crohn's and Colitis. 7. DOI: 10.1016/S1873-9946(13)60456-0 |
0.342 |
|
| 2013 |
Lovasz B, Lakatos L, Golovics P, Horvath A, Szita I, Pandur T, Mandel M, Vegh Z, Mester G, Balogh M, Molnar C, Komaromi E, Kiss L, Lakatos P. P307 Age at diagnosis 40-years is not an accurate predictor of disease outcome in patients with Crohn's disease Journal of Crohn's and Colitis. 7: S132. DOI: 10.1016/S1873-9946(13)60328-1 |
0.645 |
|
| 2013 |
Kiss L, Lovasz B, Golovics P, Vegh Z, Farkas K, Molnar T, Palatka K, Mohas A, Szilagyi B, Fekete S, Lakatos P. P203 Levels of anti-double-strained DNA but not antinuclear antibodies in patients with IBD treated by anti-TNFs are associated with adverse outcomes Journal of Crohn's and Colitis. 7: S90. DOI: 10.1016/S1873-9946(13)60225-1 |
0.632 |
|
| 2013 |
Lovasz B, Mandel M, Kiss L, Golovics P, Vegh Z, Farkas K, Molnar T, Balint A, Mohas A, Szilagyi B, Fekete S, Lakatos P. P115 Work disability in patients with inflammatory bowel diseases. Preliminary report from two referral centers Journal of Crohn's and Colitis. 7: S55. DOI: 10.1016/S1873-9946(13)60137-3 |
0.684 |
|
| 2013 |
Burisch J, Duricova D, Pedersen N, Salupere R, Tsianos E, Martinato M, Tighineanu O, Hernandez V, Lakatos P, Munkholm P. 14 Incidence and phenotype at diagnosis in paediatric IBD patients – An ECCO-EpiCom study Journal of Crohn's and Colitis. 7. DOI: 10.1016/S1873-9946(13)60015-X |
0.439 |
|
| 2012 |
Lakatos PL, Lakatos L, Kiss LS, Peyrin-Biroulet L, Schoepfer A, Vavricka S. Treatment of extraintestinal manifestations in inflammatory bowel disease. Digestion. 86: 28-35. PMID 23051724 DOI: 10.1159/000341950 |
0.658 |
|
| 2012 |
Chevaux JB, Vavricka SR, Rogler G, Lakatos PL, Schoepfer A, Peyrin-Biroulet L. Mucosal healing with anti-TNF antibodies. Digestion. 86: 16-22. PMID 23051722 DOI: 10.1159/000341957 |
0.319 |
|
| 2012 |
Lovasz BD, Golovics PA, Vegh Z, Lakatos PL. New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 45: 269-76. PMID 23010518 DOI: 10.1016/j.dld.2012.08.020 |
0.344 |
|
| 2012 |
Takács I, Benk? I, Toldy E, Wikonkál N, Szekeres L, Bodolay E, Kiss E, Jambrik Z, Szabó B, Merkely B, Valkusz Z, Kovács T, Szabó A, Grigoreff O, Nagy Z, ... ... Lakatos P, et al. [Hungarian consensus regarding the role of vitamin D in the prevention and treatment of diseases]. Orvosi Hetilap. 153: 5-26. PMID 22934332 DOI: 10.1556/Oh.2012.29410 |
0.31 |
|
| 2012 |
Kovacs M, Lakatos PL, Papp M, Jacobsen S, Nemes E, Polgar M, Solyom E, Bodi P, Horvath A, Muller KE, Molnar K, Szabo D, Cseh A, Dezsofi A, Arato A, et al. Pancreatic autoantibodies and autoantibodies against goblet cells in pediatric patients with inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 55: 429-35. PMID 22465933 DOI: 10.1097/MPG.0b013e318256b516 |
0.314 |
|
| 2012 |
Golovics PA, Lakatos PL, Dávid G, Pandur T, Erdélyi Z, Horváth A, Mester G, Balogh M, Szipocs I, Molnár C, Komáromi E, Lovász BD, Szathmári M, Kiss LS, Lakatos L. [The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study]. Orvosi Hetilap. 153: 541-52. PMID 22450143 DOI: 10.1556/Oh.2012.29331 |
0.649 |
|
| 2012 |
Kovacs M, Muller KE, Arato A, Lakatos PL, Kovacs JB, Varkonyi A, Solyom E, Polgar M, Nemes E, Guthy I, Tokodi I, Toth G, Horvath A, Tarnok A, Tomsits E, et al. Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry. Journal of Crohn's & Colitis. 6: 86-94. PMID 22261532 DOI: 10.1016/j.crohns.2011.07.008 |
0.331 |
|
| 2012 |
Lakatos PL, Golovics PA, David G, Pandur T, Erdelyi Z, Horvath A, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Veres G, Lovasz BD, Szathmari M, Kiss LS, et al. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009. The American Journal of Gastroenterology. 107: 579-88. PMID 22233693 DOI: 10.1038/Ajg.2011.448 |
0.623 |
|
| 2012 |
Miheller P, Kiss LS, Lorinczy K, Lakatos PL. Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use? Expert Opinion On Biological Therapy. 12: 179-92. PMID 22149260 DOI: 10.1517/14712598.2012.644271 |
0.651 |
|
| 2012 |
Kiss LS, Papp M, Lovasz BD, Vegh Z, Golovics PA, Janka E, Varga E, Szathmari M, Lakatos PL. High-sensitivity C-reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: a marker for patient classification? Inflammatory Bowel Diseases. 18: 1647-54. PMID 22081542 DOI: 10.1002/Ibd.21933 |
0.661 |
|
| 2012 |
Lovasz B, Lakatos L, Horvath A, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics P, Kiss L, Lakatos P. P109 Evolution of the disease behavior in pediatric and adult onset CD in a population-based incident cohort from Western Hungary Journal of Crohn's and Colitis. 6: S53-S54. DOI: 10.1055/S-0032-1312401 |
0.643 |
|
| 2012 |
Lakatos P, Lovász B, Horváth Á, Pandur T, Erdélyi Z, Mester G, Balogh M, Szipocs I, Molnár C, Komáromi E, Golovics P, Mandel M, Kiss L, Lakatos L. Low risk of lymphoma in inflammatory bowel diseases in western Hungary. Results from a population-based incident cohort Zeitschrift FüR Gastroenterologie. 50. DOI: 10.1055/S-0032-1312397 |
0.683 |
|
| 2012 |
Lakatos L, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Lovasz B, Horvath A, Golovics P, Kiss L, Lakatos P. P411 Is smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort Journal of Crohn's and Colitis. 6: S173. DOI: 10.1055/S-0032-1312377 |
0.66 |
|
| 2012 |
Lakatos L, Lovasz B, Horvath A, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Golovics P, Kiss L, Lakatos P. P415 Low risk of lymphoma in inflammatory bowel diseases in Western Hungary. Results from a population-based incident cohort Journal of Crohn's and Colitis. 6: S175. DOI: 10.1016/S1873-9946(12)60434-6 |
0.684 |
|
| 2012 |
Lovasz B, Lakatos L, Horvath A, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Veres G, Golovics P, Kiss L, Lakatos P. P410 Incidence rates and disease course of pediatric IBD in Western Hungary between 1977–2008 Journal of Crohn's and Colitis. 6: S173. DOI: 10.1016/S1873-9946(12)60429-2 |
0.622 |
|
| 2012 |
Molnár T, Farkas K, Nagy F, Lakatos P, Szepes Z, Miheller P, Horvath G, Papp M, Palatka K, Nyari T, Wittmann T. P378 High restarting rate among patients with Crohn's disease after cessation of one-year treatment period with biologicals: Result of national RASH study Journal of Crohn's and Colitis. 6. DOI: 10.1016/S1873-9946(12)60397-3 |
0.347 |
|
| 2012 |
Golovics P, Lakatos L, David G, Pandur T, Erdelyi Z, Horvath A, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Lovasz B, Kiss L, Lakatos P. P108 Is early surgery associated with a more benign disease course in Crohn's disease? Surgery rates in a population-based inception cohort from Western Hungary between 1977–2009 Journal of Crohn's and Colitis. 6: S53. DOI: 10.1016/S1873-9946(12)60128-7 |
0.642 |
|
| 2011 |
Lakatos PL, Kiss LS. Current status of thiopurine analogues in the treatment in Crohn's disease. World Journal of Gastroenterology. 17: 4372-81. PMID 22110262 DOI: 10.3748/Wjg.V17.I39.4372 |
0.65 |
|
| 2011 |
Lakatos L, Kiss LS, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Lakatos PL. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflammatory Bowel Diseases. 17: 2558-65. PMID 22072315 DOI: 10.1002/Ibd.21607 |
0.683 |
|
| 2011 |
Katsanos KH, Tatsioni A, Pedersen N, Shuhaibar M, Ramirez VH, Politi P, Rombrechts E, Pierik M, Clofent J, Beltrami M, Bodini P, Freitas J, Mouzas I, Fornaciari G, Moum B, ... Lakatos PL, et al. Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study. Journal of Crohn's & Colitis. 5: 430-42. PMID 21939917 DOI: 10.1016/j.crohns.2011.04.013 |
0.314 |
|
| 2011 |
Kiss LS, Szamosi T, Molnar T, Miheller P, Lakatos L, Vincze A, Palatka K, Barta Z, Gasztonyi B, Salamon A, Horvath G, Tóth GT, Farkas K, Banai J, Tulassay Z, ... ... Lakatos PL, et al. Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease. Alimentary Pharmacology & Therapeutics. 34: 911-22. PMID 21883326 DOI: 10.1111/J.1365-2036.2011.04827.X |
0.639 |
|
| 2011 |
Kiss LS, Szamosi T, Molnár T, Miheller P, Lakatos L, Vincze A, Palatka K, Bartha Z, Gasztonyi B, Salamon A, Horváth G, Tóth GT, Farkas K, Banai J, Tulassay Z, ... ... Lakatos PL, et al. [Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary]. Orvosi Hetilap. 152: 1433-42. PMID 21865144 DOI: 10.1556/Oh.2011.29200 |
0.645 |
|
| 2011 |
Lakatos PL, Kiss LS, Miheller P. Nutritional influences in selected gastrointestinal diseases. Digestive Diseases (Basel, Switzerland). 29: 154-65. PMID 21734379 DOI: 10.1159/000323878 |
0.656 |
|
| 2011 |
Halászlaki C, Takács I, Patócs A, Lakatos P. [Novel mutation in a patient with Carney complex]. Orvosi Hetilap. 152: 802-4. PMID 21540154 DOI: 10.1556/Oh.2011.29117 |
0.303 |
|
| 2011 |
Kiss LS, Lakatos PL. Natural history of ulcerative colitis: current knowledge. Current Drug Targets. 12: 1390-5. PMID 21466488 DOI: 10.2174/138945011796818117 |
0.651 |
|
| 2011 |
Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Kiss LS, Lakatos L. Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: a population-based study from western Hungary 1977-2008. Journal of Crohn's & Colitis. 5: 122-8. PMID 21453881 DOI: 10.1055/S-0031-1278478 |
0.684 |
|
| 2011 |
Lakatos PL, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Komaromi E, Kiss LS, Lakatos L. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. Journal of Crohn's & Colitis. 5: 5-13. PMID 21272797 DOI: 10.1016/J.Crohns.2010.08.004 |
0.635 |
|
| 2011 |
Kiss Z, Ambrus C, Almasi C, Berta K, Deak G, Horonyi P, Kiss I, Lakatos P, Marton A, Molnar MZ, Nemeth Z, Szabo A, Mucsi I. Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis. Nephron. Clinical Practice. 117: c373-8. PMID 21071961 DOI: 10.1159/000321521 |
0.31 |
|
| 2011 |
Lakatos PL, Kiss LS, Palatka K, Altorjay I, Antal-Szalmas P, Palyu E, Udvardy M, Molnar T, Farkas K, Veres G, Harsfalvi J, Papp J, Papp M. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease. Inflammatory Bowel Diseases. 17: 767-77. PMID 20865702 DOI: 10.1002/Ibd.21402 |
0.66 |
|
| 2011 |
Holb IJ, Vámos A, Lakatos P, Gáll JM, Abonyi F. Some aspects of reduced disease management against Blumeriella jaapii in sour cherry production Journal of Horticultural Science. 17. DOI: 10.31421/Ijhs/17/1-2./944 |
0.305 |
|
| 2011 |
Holb IJ, Balla B, Abonyi F, Fazekas M, Lakatos P, Gáll JM. Development and evaluation of a model for management of brown rot in organic apple orchards European Journal of Plant Pathology. 129: 469-483. DOI: 10.1007/S10658-010-9710-1 |
0.37 |
|
| 2010 |
Lakatos PL, Czegledi Z, David G, Kispal Z, Kiss LS, Palatka K, Kristof T, Nagy F, Salamon A, Demeter P, Miheller P, Szamosi T, Banai J, Papp M, Bene L, et al. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. Journal of Crohn's & Colitis. 4: 283-90. PMID 21122517 DOI: 10.1016/J.Crohns.2009.11.011 |
0.678 |
|
| 2010 |
Meggyesi N, Kiss LS, Koszarska M, Bortlik M, Duricova D, Lakatos L, Molnar T, Leniček M, Vítek L, Altorjay I, Papp M, Tulassay Z, Miheller P, Papp J, Tordai A, ... ... Lakatos PL, et al. NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients. World Journal of Gastroenterology. 16: 5233-40. PMID 21049557 DOI: 10.3748/Wjg.V16.I41.5233 |
0.656 |
|
| 2010 |
Miheller P, Lakatos PL. Thiopurines in Crohn's disease, is there something new? Expert Opinion On Drug Metabolism & Toxicology. 6: 1505-14. PMID 20919963 DOI: 10.1517/17425255.2010.525505 |
0.323 |
|
| 2010 |
Halászlaki C, Horváth H, Kiss L, Takács I, Speer G, Nagy Z, Winternitz T, Dabasi G, Zalatnai A, Patócs A, Lakatos P. [Verner-Morrison syndrome: a case study]. Orvosi Hetilap. 151: 1111-4. PMID 20558361 DOI: 10.1556/Oh.2010.28884 |
0.598 |
|
| 2010 |
Lakatos PL, Kiss LS. Is the disease course predictable in inflammatory bowel diseases? World Journal of Gastroenterology. 16: 2591-9. PMID 20518079 DOI: 10.3748/Wjg.V16.I21.2591 |
0.684 |
|
| 2010 |
Lakatos PL. Prediction of disease course in inflammatory bowel diseases. World Journal of Gastroenterology. 16: 2589-90. PMID 20518078 DOI: 10.3748/wjg.v16.i21.2589 |
0.357 |
|
| 2010 |
Kiss LS, Lakatos PL. [Prediction of the disease course in inflammatory bowel diseases]. Orvosi Hetilap. 151: 293-301. PMID 20154000 DOI: 10.1556/Oh.2010.28813 |
0.684 |
|
| 2010 |
Lakatos L, Czeglédi Z, Dávid G, Kispál Z, Kiss LS, Palatka K, Kristóf T, Molnár T, Salamon A, Demeter P, Miheller P, Szamosi T, Banai J, Papp M, Bene L, ... ... Lakatos PL, et al. [Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease]. Orvosi Hetilap. 151: 250-8. PMID 20133244 DOI: 10.1556/Oh.2010.28805 |
0.662 |
|
| 2010 |
Papp M, Lakatos PL, Harsfalvi J, Farkas G, Palatka K, Udvardy M, Molnar T, Farkas K, Nagy F, Veres G, Lakatos L, Kovacs A, Dinya T, Kocsis AK, Papp J, et al. Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort. Human Immunology. 71: 407-13. PMID 20079790 DOI: 10.1016/j.humimm.2010.01.012 |
0.33 |
|
| 2010 |
Lakatos PL. Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails? Reviews On Recent Clinical Trials. 4: 152-8. PMID 20028325 DOI: 10.2174/157488709789957664 |
0.31 |
|
| 2010 |
Holb IJ, Lakatos P, Abonyi F. Some aspects of disease management of cherry leaf spot (Blumeriella jaapii) with special reference to pesticide use Journal of Horticultural Science. 16. DOI: 10.31421/Ijhs/16/1/862 |
0.322 |
|
| 2010 |
Lakatos L, David G, Pandur T, Erdelyi Z, Mester G, Balogh M, Szipocs I, Molnar C, Horvath A, Komaromi E, Kiss L, Lakatos P. Incidence and early disease course of ulcerative colitis in Western Hungary between 2002–2006 Zeitschrift FüR Gastroenterologie. 48. DOI: 10.1055/S-0030-1254776 |
0.667 |
|
| 2009 |
Lakatos PL, Czegledi Z, Szamosi T, Banai J, David G, Zsigmond F, Pandur T, Erdelyi Z, Gemela O, Papp J, Lakatos L. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease. World Journal of Gastroenterology : Wjg. 15: 3504-10. PMID 19630105 |
0.317 |
|
| 2009 |
Lakatos PL, Altorjay I, Szamosi T, Palatka K, Vitalis Z, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Barta Z, et al. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort. Inflammatory Bowel Diseases. 15: 365-74. PMID 18972554 DOI: 10.1002/Ibd.20778 |
0.335 |
|
| 2009 |
Szamosi T, Lakatos PL, Szilvasi A, Lakatos L, Kovacs A, Molnar T, Altorjay I, Papp M, Szabo O, Satori A, Tulassay Z, Miheller P, Horvath HC, Papp J, et al. The 3'UTR NFKBIA variant is associated with extensive colitis in Hungarian IBD patients. Digestive Diseases and Sciences. 54: 351-9. PMID 18716880 DOI: 10.1007/S10620-008-0351-6 |
0.366 |
|
| 2009 |
Veres G, Papp M, Lakatos P. P252 - Characteristics of patients prospectively recruited in the Hungarian Pediatric IBD Registry (HUPIR) Journal of Crohn's and Colitis. 3. DOI: 10.1016/S1873-9946(09)60279-8 |
0.342 |
|
| 2008 |
Bácsi K, Hitre E, Kósa JP, Horváth H, Lazáry Á, Lakatos PL, Balla B, Budai B, Lakatos P, Speer G. Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population. Bmc Cancer. 8: 317-317. PMID 18980667 DOI: 10.1186/1471-2407-8-317 |
0.31 |
|
| 2008 |
Kocsis AK, Lakatos PL, Somogyvári F, Fuszek P, Papp J, Fischer S, Szamosi T, Lakatos L, Kovacs A, Hofner P, Mándi Y. Association of beta-defensin 1 single nucleotide polymorphisms with Crohn's disease. Scandinavian Journal of Gastroenterology. 43: 299-307. PMID 18938660 DOI: 10.1080/00365520701682615 |
0.642 |
|
| 2008 |
Lakatos PL, Fuszek P, Horvath HC, Zubek L, Haller P, Papp J. Double-balloon enteroscopy for the diagnosis and treatment of obscure bleeding, inflammatory bowel diseases and polyposis syndromes: we see more but do we know more? Hepato-Gastroenterology. 55: 133-7. PMID 18507092 DOI: 10.1055/S-2007-982680 |
0.396 |
|
| 2008 |
Lakatos PL, Altorjay I, Mándi Y, Lakatos L, Tumpek J, Kovacs A, Molnar T, Tulassay Z, Miheller P, Palatka K, Szamosi T, Fischer S, Papp J, Papp M. Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins? Tissue Antigens. 71: 552-9. PMID 18397186 DOI: 10.1055/S-2008-1079623 |
0.67 |
|
| 2008 |
Papp M, Foldi I, Nemes E, Udvardy M, Harsfalvi J, Altorjay I, Mate I, Dinya T, Varvolgyi C, Barta Z, Veres G, Lakatos PL, Tumpek J, Toth L, Szathmari E, et al. Haptoglobin polymorphism: A novel genetic risk factor for celiac disease development and its clinical manifestations Clinical Chemistry. 54: 697-704. PMID 18258668 DOI: 10.1373/clinchem.2007.098780 |
0.306 |
|
| 2008 |
Papp M, Altorjay I, Dotan N, Palatka K, Foldi I, Tumpek J, Sipka S, Udvardy M, Dinya T, Lakatos L, Kovacs A, Molnar T, Tulassay Z, Miheller P, Norman GL, ... ... Lakatos PL, et al. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort. The American Journal of Gastroenterology. 103: 665-81. PMID 18047543 DOI: 10.1111/J.1572-0241.2007.01652.X |
0.344 |
|
| 2008 |
Cervený P, Bortlík M, Kubena A, Vlcek J, Lakatos PL, Lukás M. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflammatory Bowel Diseases. 13: 1244-9. PMID 17538983 DOI: 10.1002/ibd.20189 |
0.354 |
|
| 2008 |
Reginster J, Adami S, Lakatos P, Greenwald M, Stepan JJ, Silverman SL. Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 Year results from the MOBILE study (Annals of the Rheumatic Diseases (2006) 65, (654-661)) Annals of the Rheumatic Diseases. 67. DOI: 10.1136/Ard.2005.044958.Corr1 |
0.35 |
|
| 2007 |
Molnar T, Hofner P, Nagy F, Lakatos PL, Fischer S, Lakatos L, Kovacs A, Altorjay I, Papp M, Palatka K, Demeter P, Tulassay Z, Nyari T, Miheller P, Papp J, et al. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 39: 1064-70. PMID 17964870 DOI: 10.1016/J.Dld.2007.09.003 |
0.681 |
|
| 2007 |
Miheller P, Muzes G, Rácz K, Blázovits A, Lakatos P, Herszényi L, Tulassay Z. Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy. Inflammatory Bowel Diseases. 13: 1379-84. PMID 17663430 DOI: 10.1002/Ibd.20234 |
0.365 |
|
| 2007 |
Lakatos L, Lakatos PL. [Medical therapy of inflammatory bowel diseases: Crohn's disease]. Orvosi Hetilap. 148: 1107-14. PMID 17561480 DOI: 10.1556/OH.2007.28062 |
0.314 |
|
| 2007 |
Fischer S, Lakatos PL, Lakatos L, Kovacs A, Molnar T, Altorjay I, Papp M, Szilvasi A, Tulassay Z, Osztovits J, Papp J, Demeter P, Schwab R, Tordai A, et al. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases. Scandinavian Journal of Gastroenterology. 42: 726-33. PMID 17505995 DOI: 10.1080/00365520601101559 |
0.669 |
|
| 2007 |
Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of serological markers in inflammatory bowel diseases: gadget or magic? World Journal of Gastroenterology. 13: 2028-36. PMID 17465443 DOI: 10.3748/wjg.v13.i14.2028 |
0.317 |
|
| 2007 |
Papp M, Altorjay I, Norman GL, Shums Z, Palatka K, Vitalis Z, Foldi I, Lakos G, Tumpek J, Udvardy ML, Harsfalvi J, Fischer S, Lakatos L, Kovacs A, Bene L, ... ... Lakatos PL, et al. Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients. Inflammatory Bowel Diseases. 13: 984-92. PMID 17417801 DOI: 10.1002/Ibd.20146 |
0.688 |
|
| 2007 |
Bácsi K, Kósa J, Lazáry Á, Horváth H, Balla B, Lakatos P, Speer G. Importance of dehydroepiandrosterone and dehydroepiandrosterone sulfate in different diseases Orvosi Hetilap. 148: 651-657. PMID 17403638 DOI: 10.1556/Oh.2007.27903 |
0.323 |
|
| 2007 |
Lakatos PL, Hitre E, Szalay F, Zinober K, Fuszek P, Lakatos L, Fischer S, Osztovits J, Gemela O, Veres G, Papp J, Ferenci P. Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. Bmc Cancer. 7: 54. PMID 17389035 DOI: 10.1186/1471-2407-7-54 |
0.66 |
|
| 2007 |
Lakatos L, Lakatos PL. [Changes in the epidemiology of inflammatory bowel diseases]. Orvosi Hetilap. 148: 223-8. PMID 17344143 DOI: 10.1556/OH.2007.27906 |
0.324 |
|
| 2007 |
Folhoffer A, Ferenci P, Csak T, Horvath A, Hegedus D, Firneisz G, Osztovits J, Kosa JP, Willheim-Polli C, Szonyi L, Abonyi M, Lakatos PL, Szalay F. Novel mutations of the ATP7B gene among 109 Hungarian patients with Wilson's disease. European Journal of Gastroenterology & Hepatology. 19: 105-11. PMID 17272994 DOI: 10.1097/01.MEG.0000223904.70492.0B |
0.308 |
|
| 2007 |
Miheller P, Műzes G, Rácz K, Blázovits A, Lakatos P, Herszényi L, Tulassay Z. Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy Zeitschrift FüR Gastroenterologie. 45. DOI: 10.1055/S-2007-982689 |
0.363 |
|
| 2006 |
Papp M, Lakatos PL, Fuszek P, Simon F, Szalay F, Osztovics J, Horvath HC, Vargha P, Bene L, Lonovics J, Nagy F, Bálint L, Huoranszky F, Dobó I, Tulassay Z, et al. Haptoglobin polymorphism in patients with inflammatory diseases Orvosi Hetilap. 147: 1745-1750. PMID 17087019 |
0.345 |
|
| 2006 |
Lakatos PL, Fischer S, Lakatos L. Is the epidemiology of inflammatory bowel disease changing in Eastern Europe? Scandinavian Journal of Gastroenterology. 41: 870-1; author reply . PMID 16785204 DOI: 10.1080/00365520600636167 |
0.67 |
|
| 2006 |
Fuszek P, Horvath HC, Speer G, Papp J, Haller P, Fischer S, Halasz J, Jaray B, Szekely E, Schaff Z, Papp A, Bursics A, Harsanyi L, Lukovich P, Kupcsulik P, ... ... Lakatos PL, et al. Location and age at onset of colorectal cancer in Hungarian patients between 1993 and 2004. The high number of advanced cases supports the need for a colorectal cancer screening program in Hungary. Anticancer Research. 26: 527-31. PMID 16739314 |
0.584 |
|
| 2006 |
Lakatos PL, Fischer S, Claes K, Kovacs A, Molnar T, Altorjay I, Demeter P, Tulassay Z, Palatka K, Papp M, Rutgeerts P, Szalay F, Papp J, Vermeire S, Lakatos L, et al. DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease. Inflammatory Bowel Diseases. 12: 362-8. PMID 16670524 DOI: 10.1055/S-2006-943435 |
0.682 |
|
| 2006 |
Lakatos PL, Fekete S, Horanyi M, Fischer S, Abonyi ME. Development of multiple myeloma in a patient with chronic hepatitis C: A case report and review of the literature World Journal of Gastroenterology. 12: 2297-2300. PMID 16610042 DOI: 10.3748/Wjg.V12.I14.2297 |
0.582 |
|
| 2006 |
Lakatos PL, Fischer S, Lakatos L, Gal I, Papp J. Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ? World Journal of Gastroenterology. 12: 1829-41. PMID 16609988 DOI: 10.3748/Wjg.V12.I12.1829 |
0.658 |
|
| 2006 |
Lakatos L, Mester G, Erdelyi Z, David G, Pandur T, Balogh M, Fischer S, Vargha P, Lakatos PL. Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study. Inflammatory Bowel Diseases. 12: 205-11. PMID 16534422 DOI: 10.1097/01.Mib.0000217770.21261.Ce |
0.637 |
|
| 2006 |
Lakatos L, Mester G, Erdélyi Z, David G, Pandúr T, Balogh M, Fischer S, Vargha P, Lakatos PL. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients]. Orvosi Hetilap. 147: 175-81. PMID 16515026 |
0.631 |
|
| 2005 |
Lakatos PL, Szalay F, Tulassay Z, Molnar T, Kovacs A, Gasztonyi B, Papp J, Lakatos L. Clinical presentation of Crohn's disease. association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery. Hepato-Gastroenterology. 52: 817-22. PMID 15966211 |
0.339 |
|
| 2005 |
Lakatos P, Szalay F, Tulassay Z, Molnar T, Kovacs A, Gasztonyi B, Papp J, Lakatos L. Clinical presentation of Crohn's disease: association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery Zeitschrift Fur Gastroenterologie. 43: 69. DOI: 10.1055/S-2005-869716 |
0.387 |
|
| 2005 |
Lakatos L, Lakatos P, Szalay F, Willheim-Polli C, Österreicher C, Tulassay Z, Molnar T, Reinisch W, Papp J, Mozsik G, Ferenci P. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations Zeitschrift Fur Gastroenterologie. 43: 68. DOI: 10.1055/S-2005-869715 |
0.35 |
|
| 2004 |
Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C, Farkas H, Fáy K, ... ... Lakatos P, et al. Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. The Journal of Allergy and Clinical Immunology. 114: S51-131. PMID 15356535 DOI: 10.1016/J.Jaci.2004.06.047 |
0.326 |
|
| 2004 |
Lakatos PL, Bajnok E, Tornai I, Folhoffer A, Horvath A, Lakatos P, Habior A, Szalay F. Insulin-like growth factor I gene microsatellite repeat, collagen type Iα1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis European Journal of Gastroenterology & Hepatology. 16: 753-759. PMID 15256976 DOI: 10.1097/01.Meg.0000108364.41221.D0 |
0.313 |
|
| 2004 |
Lakatos L, Mester G, Erdelyi Z, Balogh M, Szipocs I, Kamaras G, Lakatos PL. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World Journal of Gastroenterology. 10: 404-9. PMID 14760767 DOI: 10.3748/wjg.v10.i3.404 |
0.321 |
|
| 2004 |
Lakatos L, Mester G, Erdélyi Z, Balogh M, Szipócs I, Kamarás G, Lakatos PL. [Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001]. Orvosi Hetilap. 144: 1819-27. PMID 14596020 |
0.33 |
|
| 2004 |
Csák T, Folhoffer A, Horvath A, Szeli D, Lakatos P, Szalay F. Adie's syndrome and mesenterial lymphangioma in a patient with celiac disease and autoimmune hepatitis Zeitschrift Fur Gastroenterologie. 42. DOI: 10.1055/S-2004-827122 |
0.366 |
|
| 2004 |
Lakatos L, Lakatos P, Szalay F, Willheim-Polli C, Tulassay Z, Molnar T, Reinisch W, Österreicher C, Papp J. Common NOD2/CARD15 alleles and other EXON4 mutations in 527 hungarian patients with Crohn's disease: Genotype-phenotype associations Zeitschrift Fur Gastroenterologie. 42. DOI: 10.1055/S-2004-826979 |
0.358 |
|
| 2003 |
Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World Journal of Gastroenterology. 9: 2300-7. PMID 14562397 |
0.344 |
|
| Show low-probability matches. |